annual D&A:
$4.99B-$40.13M(-0.80%)Summary
- As of today (September 17, 2025), TAK annual depreciation & amortization is $4.99 billion, with the most recent change of -$40.13 million (-0.80%) on March 1, 2025.
- During the last 3 years, TAK annual D&A has fallen by -$195.05 million (-3.76%).
- TAK annual D&A is now -6.96% below its all-time high of $5.37 billion, reached on March 31, 2020.
Performance
TAK Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.26B+$44.89M(+3.70%)Summary
- As of today (September 17, 2025), TAK quarterly depreciation & amortization is $1.26 billion, with the most recent change of +$44.89 million (+3.70%) on June 1, 2025.
- Over the past year, TAK quarterly D&A has increased by +$23.54 million (+1.91%).
- TAK quarterly D&A is now -8.13% below its all-time high of $1.37 billion, reached on June 30, 2019.
Performance
TAK quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.00B+$23.54M(+0.47%)Summary
- As of today (September 17, 2025), TAK TTM depreciation & amortization is $5.00 billion, with the most recent change of +$23.54 million (+0.47%) on June 1, 2025.
- Over the past year, TAK TTM D&A has dropped by -$9.67 million (-0.19%).
- TAK TTM D&A is now -6.26% below its all-time high of $5.34 billion, reached on March 31, 2020.
Performance
TAK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TAK Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.8% | +1.9% | -0.2% |
| 3 y3 years | -3.8% | +3.1% | -2.3% |
| 5 y5 years | -7.0% | -4.5% | -5.3% |
TAK Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +1.9% | -3.5% | +4.1% | -2.3% | +1.6% |
| 5 y | 5-year | -7.0% | +1.9% | -8.0% | +4.1% | -6.0% | +1.6% |
| alltime | all time | -7.0% | +2865.8% | -8.1% | +694.9% | -6.3% | +1507.5% |
TAK Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.26B(+3.7%) | $5.00B(+0.5%) |
| Mar 2025 | $4.99B(-0.8%) | $1.21B(-6.2%) | $4.98B(-1.8%) |
| Dec 2024 | - | $1.29B(+4.1%) | $5.07B(+1.3%) |
| Sep 2024 | - | $1.24B(+0.7%) | $5.01B(-0.1%) |
| Jun 2024 | - | $1.23B(-5.4%) | $5.01B(-0.3%) |
| Mar 2024 | $5.03B(+2.7%) | $1.30B(+6.2%) | $5.03B(+0.4%) |
| Dec 2023 | - | $1.23B(-1.8%) | $5.01B(+0.2%) |
| Sep 2023 | - | $1.25B(+0.2%) | $5.00B(+0.9%) |
| Jun 2023 | - | $1.25B(-2.8%) | $4.95B(+0.6%) |
| Mar 2023 | $4.90B(-5.5%) | $1.28B(+5.6%) | $4.92B(-0.8%) |
| Dec 2022 | - | $1.22B(+0.7%) | $4.96B(-1.7%) |
| Sep 2022 | - | $1.21B(-1.0%) | $5.05B(-1.3%) |
| Jun 2022 | - | $1.22B(-7.9%) | $5.12B(-1.7%) |
| Mar 2022 | $5.19B(-1.7%) | $1.32B(+1.6%) | $5.21B(-0.8%) |
| Dec 2021 | - | $1.30B(+2.1%) | $5.25B(-0.6%) |
| Sep 2021 | - | $1.28B(-2.4%) | $5.28B(-0.6%) |
| Jun 2021 | - | $1.31B(-4.4%) | $5.32B(-0.2%) |
| Mar 2021 | $5.28B(-1.7%) | $1.37B(+2.3%) | $5.33B(+1.3%) |
| Dec 2020 | - | $1.34B(+2.3%) | $5.26B(+0.1%) |
| Sep 2020 | - | $1.31B(-0.8%) | $5.25B(-0.7%) |
| Jun 2020 | - | $1.32B(+1.5%) | $5.29B(-1.0%) |
| Mar 2020 | $5.37B(+140.3%) | $1.30B(-2.4%) | $5.34B(+1.9%) |
| Dec 2019 | - | $1.33B(-1.2%) | $5.24B(+23.5%) |
| Sep 2019 | - | $1.34B(-1.7%) | $4.24B(+30.5%) |
| Jun 2019 | - | $1.37B(+14.5%) | $3.25B(+45.4%) |
| Mar 2019 | $2.23B(+35.9%) | $1.20B(+261.3%) | $2.23B(+46.1%) |
| Dec 2018 | - | $330.92M(-6.5%) | $1.53B(-3.4%) |
| Sep 2018 | - | $354.08M(+0.2%) | $1.58B(+0.7%) |
| Jun 2018 | - | $353.26M(-28.1%) | $1.57B(-3.7%) |
| Mar 2018 | $1.64B(+3.8%) | $491.04M(+27.6%) | $1.63B(+25.6%) |
| Dec 2017 | - | $384.87M(+12.2%) | $1.30B(-0.4%) |
| Sep 2017 | - | $343.16M(-17.1%) | $1.31B(-17.0%) |
| Jun 2017 | - | $413.89M(+161.7%) | $1.57B(+0.5%) |
| Mar 2017 | $1.58B(-3.7%) | $158.14M(-59.4%) | $1.57B(-15.8%) |
| Dec 2016 | - | $389.89M(-36.2%) | $1.86B(-1.5%) |
| Sep 2016 | - | $611.38M(+50.6%) | $1.89B(+14.4%) |
| Jun 2016 | - | $405.90M(-10.3%) | $1.65B(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | $1.64B(-30.8%) | $452.40M(+8.3%) | $1.65B(-10.8%) |
| Dec 2015 | - | $417.56M(+11.8%) | $1.85B(-15.4%) |
| Sep 2015 | - | $373.48M(-7.4%) | $2.18B(-5.0%) |
| Jun 2015 | - | $403.21M(-38.0%) | $2.30B(-2.7%) |
| Mar 2015 | $2.38B(+10.3%) | $650.78M(-13.7%) | $2.36B(+38.0%) |
| Dec 2014 | - | $754.43M(+54.3%) | $1.71B(+78.9%) |
| Sep 2014 | - | $488.96M(+4.6%) | $956.44M(+104.6%) |
| Jun 2014 | - | $467.48M(+26.8%) | $467.48M(-62.8%) |
| Mar 2014 | $2.15B(-27.8%) | - | - |
| Mar 2013 | $2.98B(+56.8%) | - | - |
| Mar 2012 | $1.90B(+52.6%) | - | - |
| Mar 2011 | $1.25B(+0.8%) | $368.63M(+20.6%) | $1.26B(+6.0%) |
| Dec 2010 | - | $305.75M(+2.3%) | $1.19B(-1.2%) |
| Sep 2010 | - | $298.86M(+5.1%) | $1.20B(-1.4%) |
| Jun 2010 | - | $284.34M(-4.5%) | $1.22B(-2.2%) |
| Mar 2010 | $1.24B(+5.3%) | $297.72M(-7.2%) | $1.25B(+31.4%) |
| Dec 2009 | - | $320.71M(+1.6%) | $947.69M(+51.2%) |
| Sep 2009 | - | $315.67M(+1.4%) | $626.98M(+101.4%) |
| Jun 2009 | - | $311.31M | $311.31M |
| Mar 2009 | $1.17B(+323.4%) | - | - |
| Mar 2008 | $277.28M(+12.5%) | - | - |
| Mar 2007 | $246.51M(-2.9%) | - | - |
| Mar 2006 | $253.80M(-12.6%) | - | - |
| Mar 2005 | $290.50M(+16.9%) | - | - |
| Mar 2004 | $248.52M(+1.1%) | - | - |
| Mar 2003 | $245.79M(+8.0%) | - | - |
| Mar 2002 | $227.51M(-25.1%) | - | - |
| Mar 2001 | $303.89M(+1.4%) | - | - |
| Mar 2000 | $299.60M(+16.6%) | - | - |
| Mar 1999 | $256.96M(-0.8%) | - | - |
| Mar 1998 | $259.00M(-7.1%) | - | - |
| Mar 1997 | $278.85M(-19.2%) | - | - |
| Mar 1996 | $345.00M(+14.0%) | - | - |
| Mar 1995 | $302.74M(+16.0%) | - | - |
| Mar 1994 | $261.07M(+17.6%) | - | - |
| Mar 1993 | $221.99M(+12.4%) | - | - |
| Mar 1992 | $197.54M(+17.3%) | - | - |
| Mar 1991 | $168.40M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual depreciation & amortization?
- What is the all time high annual D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual D&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly D&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM D&A year-on-year change?
What is Takeda Pharmaceutical Company Limited annual depreciation & amortization?
The current annual D&A of TAK is $4.99B
What is the all time high annual D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual depreciation & amortization is $5.37B
What is Takeda Pharmaceutical Company Limited annual D&A year-on-year change?
Over the past year, TAK annual depreciation & amortization has changed by -$40.13M (-0.80%)
What is Takeda Pharmaceutical Company Limited quarterly depreciation & amortization?
The current quarterly D&A of TAK is $1.26B
What is the all time high quarterly D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly depreciation & amortization is $1.37B
What is Takeda Pharmaceutical Company Limited quarterly D&A year-on-year change?
Over the past year, TAK quarterly depreciation & amortization has changed by +$23.54M (+1.91%)
What is Takeda Pharmaceutical Company Limited TTM depreciation & amortization?
The current TTM D&A of TAK is $5.00B
What is the all time high TTM D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM depreciation & amortization is $5.34B
What is Takeda Pharmaceutical Company Limited TTM D&A year-on-year change?
Over the past year, TAK TTM depreciation & amortization has changed by -$9.67M (-0.19%)